Chairs: T de Villiers and C Cooper

Members: J Cannata-Andia, HP Dimai, P Ebeling, J Foldes, P Hadji, K Javaid, JA Kanis, D Kendler, M McClung, R Rizzoli

To clarify the benefit-risk ratio of oestrogen/oestrogen-progesterone therapies on bone health in women.

To make recommendations on the role of MHT for prevention and treatment of postmenopausal osteoporosis.